The Oncology Institute, Inc. TOI Specialty pharmacy — Depreciation expense

Other segment segments

Similar metrics at other companies

ASHSpecialty Additives — Depreciation

$13M0.0%

SUNBSpecialty — Depreciation

$141M+6.0%

TMOSpecialty Diagnostics — Depreciation of property, plant and equipment

$24M+9.1%

PRMSpecialty Products — Depreciation and amortization expense

$12.65M+206%

BTSGPharmacy Solutions — Depreciation And Amortization Expense From Reportable

$25.33M-7.9%

GTLSSpecialty Products — Depreciation expense

$7.4M+48.0%

Questions, answered.

What is The Oncology Institute, Inc.'s specialty pharmacy — depreciation expense?

The Oncology Institute, Inc. (TOI) reported specialty pharmacy — depreciation expense of $3K in Q1 2026.

How has The Oncology Institute, Inc.'s specialty pharmacy — depreciation expense changed year-over-year?

The Oncology Institute, Inc.'s specialty pharmacy — depreciation expense decreased by 90.6% year-over-year, from $32K to $3K.

What does specialty pharmacy — depreciation expense mean?

This represents the non-cash allocation of the cost of tangible assets used specifically within the specialty pharmacy segment over their useful lives. It reflects the wear and tear or obsolescence of equipment, such as specialized storage or dispensing technology, required to support pharmacy operations. Monitoring this helps investors understand the capital intensity and reinvestment requirements of the segment's infrastructure.